Management of hydrometra with or without ovarian follicular cysts in goats

The objective of the study was to standardize a protocol for the treatment of hydrometra with or without follicular ovarian cysts in goats. A total of 41 goats (11 Kanni Adu, 17 Kodi Adu and 13 Salem Black) affected with hydrometra were treated with cloprostenol (125μg, intramuscular) on days 0 and 10. They were divided into Gr 1: hydrometra without follicular cyst (n=27), Gr 2: hydrometra with follicular cyst (n=7) and additionally treated with buserelin acetate (10 μg, intramuscular) and Gr 3: hydrometra with follicular cyst (n=7) and additionally treated with human chorionic gonadotropin (600IU, intramuscular) on day 3. Ultrasonography showed complete drainage of uterine fluid after the first and second doses of cloprostenol in 63.41% (26/41) and 90.12% (37/41) of goats, respectively. Serum progesterone level was above 1 ng/ml on day 0 in all the goats. In Gr 2 and 3, involution of cyst was observed in 100 and 57.14% of goats, respectively. All the goats were mated after the second dose of cloprostenol, out of which 77.77% (30/41) conceived successfully in the first oestrus after treatment. It was concluded that PGF2αon days 0 and 10 along with GnRH therapy on day 3 was found to be a novel approach to augment fertility in hydrometra-affected goats with or without ovarian follicular cysts.